• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pfizer Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 434.0
  • ISIN : INE182A01018
4,004.50 31 (0.79%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    3,954.65

  • Today’s High

    4,104.90

  • Open

    3,970.00

  • Perv Close

    3,973.05

  • 52W Low

    3,865.00

  • 52W High

    6,451.15

Key Indicators

  • P/E(TTM)

    29.76

  • Mar.Cap (₹Cr.)

    18,319.68

  • Div & Yield %

    0.87

  • Book Value(₹)

    819.90

  • Debt-Equity Ratio

    0.79

  • AGM Date

    28-Mar-2025

  • EPS

    134.55

  • P/E Ratio

    29.76

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    18,319.68

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    45.75

  • BV (₹)

    819.90

  • Sales( ₹ in Cr.)

    2,193.17

  • NP (in Cr.)

    547.71

  • NP Var(%)

    -9.0

  • Div%

    350.0

  • CPS (₹)

    133.30

  • EPS (₹)

    119.70

  • Traded Value (₹ in Lakhs)

    18,317.16

  • 52 Week High

    6,451.15

  • 52 Week Low

    3,865.00

  • Price BSE

    4004.0

  • Price NSE

    4,005.00

  • Market Capital( in Cr.)

    18,317.16

  • P/C Ratio

    30.00

  • P/E Ratio

    33.40

  • Price Vs.BV

    119.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50
Excise Duty 2,081.04 2,337.63 2,530.28 2,190.04 2,096.32 2,030.49
Net Sales 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50
Other Income 180.51 101.05 62.65 81.12 184.02 167.39
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2,373.68 2,525.81 2,673.64 2,319.67 2,335.67 2,248.89
EXPENDITURE :
Raw Materials 2,081.04 2,337.63 2,530.28 2,190.04 2,096.32 2,030.49
Power & Fuel Cost 2,081.04 2,337.63 2,530.28 2,190.04 2,096.32 2,030.49
Employee Cost 347.80 331.68 403.67 361.06 364.51 323.84
Other Manufacturing Expenses 44.39 54.38 47.31 35.01 37.22 35.25
Selling & Administrative Expenses 317.96 298.03 310.77 266.57 319.66 335.32
Miscellaneous Expenses 44.39 54.38 47.31 35.01 37.22 35.25
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,635.56 1,734.80 1,900.75 1,650.95 1,693.18 1,588.98
Operating Profit 55.15 58.14 65.48 66.05 65.30 73.99
Interest 15.41 13.39 10.49 15.11 10.85 1.29
Gross Profit 746.07 824.01 772.89 668.72 642.49 659.91
Depreciation 62.28 105.51 115.00 109.41 103.24 71.39
Profit Before Tax 746.07 824.01 772.89 668.72 642.49 659.91
Tax 158.92 251.82 218.33 183.63 177.70 243.77
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 36.11 -51.91 -35.93 -12.52 0.16 -12.91
Reported Net Profit 551.33 623.93 612.56 497.61 509.13 429.05
Extraordinary Items 746.07 824.01 772.89 668.72 642.49 659.91
Adjusted Net Profit 551.33 623.93 612.56 497.61 509.13 429.05
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 160.12 320.25 160.12 160.13 1,509.76 102.94
P & L Balance carried down 551.33 623.93 612.56 497.61 509.13 429.05
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 350.00 700.00 350.00 350.00 3,300.00 225.00
Dividend Per Share(Rs) 35.00 70.00 35.00 35.00 330.00 22.50
Earnings Per Share-Unit Curr 120.51 136.38 133.89 108.77 111.28 93.78
Book Value 160.12 320.25 160.12 160.13 1,509.76 102.94
Book Value(Adj)-Unit Curr 160.12 320.25 160.12 160.13 1,509.76 102.94

Shareholding Pattern

  • Promoter Group

    63.92%

  • Public Share Holding

    36.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 29,243,042 63.92 29,243,042 7
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 29,243,042 63.92 29,243,042 7
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 188 0.00 125 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,972 0.02 5,973 18
Foreign Bank 186 0.00 0 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,256,739 2.75 1,256,728 86
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,465,223 5.39 2,465,223 12
Mutual Funds / UTI 5,170,217 11.30 5,169,717 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 40,409 0.09 40,409 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,939,934 19.54 8,938,175 151
2] Non Institution
Bodies Corporate 1,214,219 2.65 1,209,437 575
Clearing Members 182 0.00 180 5
Directors of their Relatives 2,162 0.00 2,162 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 233,023 0.51 232,259 2,827
Foreign Non Institution Other 310 0.00 0 2
Hindu Undivided Families 141,543 0.31 141,543 2,050
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 212,808 0.47 212,808 7
Individuals holding nominal share capital up to Rs. 1 lakh 5,332,746 11.66 5,034,822 99,374
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,212 0.01 4,177 10
Others 423,551 0.93 423,551 2
Sub Total 7,564,756 16.54 7,260,939 104,857
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 45,747,732 100.00 45,442,156 105,015

Company Background

Pfizer LtdPharmaceuticals - Multinational

  • Pfizer Ltd
  • BSE Code : 434.0
  • ISIN : INE182A01018

  • Incorporation Year

    1950

  • Registered Office

    The Capital 1802/1901 Plot-C70
    G Bl Bandra Kurla Cpx Bandra-E, Mumbai,
    Maharashtra-400051

  • Telephone

    91-22-66932000

  • FAX

    91-22-26540274

  • Chairman

    Pradip P Shah

  • Managing Director

    Meenakshi Nevatia

  • Company Secretary

    Prajeet Nair

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Pfizer Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pfizer 4,003.95 2,373.68 2,193.17 29.76 21.43
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92